Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 4:21 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 9,426 | $13.23 | $124,684 | 82,485 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 4:19 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 61,329 | $13.23 | $811,212 | 96,000 (Direct) | View |
| 2024-03-28 Sale | 2024-04-01 4:14 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 5,126 | $13.2 | $67,668 | 2,598 (Direct) | View |
| 2024-03-19 Sale | 2024-03-19 8:36 pm | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 4,116 | $6.0986 | $25,102 | 60,046 (Direct) | View |
| 2024-03-19 Sale | 2024-03-19 8:34 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 4,116 | $6.0986 | $25,102 | 50,769 (Direct) | View |
| 2024-03-19 Sale | 2024-03-19 8:31 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 4,116 | $6.0986 | $25,102 | 50,629 (Direct) | View |
| 2024-03-19 Sale | 2024-03-19 8:30 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 11,150 | $6.0986 | $67,999 | 175,850 (Direct) | View |
| 2024-03-19 Sale | 2024-03-19 8:29 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 2,349 | $6.0986 | $14,326 | 30,149 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:21 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 10,000 | $7.7469 | $77,469 | 82,927 (Direct) | View |
| 2024-02-01 Sale | 2024-02-05 4:32 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 10,000 | $4.7991 | $47,991 | 6,981 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 4:38 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 10,000 | $5.7352 | $57,352 | 16,981 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 5:20 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 15,000 | $10.6 | $158,973 | 25,895 (Direct) | View |
| 2023-06-21 Sale | 2023-06-23 4:45 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec | 1,948 | $13.48 | $26,252 | 0 (Direct) | View |
| 2023-06-01 Sale | 2023-06-05 7:31 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 15,000 | $11.13 | $166,964 | 40,895 (Direct) | View |
| 2023-05-04 Sale | 2023-05-08 7:35 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 653 | $10 | $6,530 | 55,895 (Direct) | View |
| 2023-05-01 Sale | 2023-05-03 8:04 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 55,177 | $10.06 | $555,267 | 56,548 (Direct) | View |
| 2023-02-03 Sale | 2023-02-07 5:08 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 12,998 | $10.02 | $130,236 | 111,725 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 6:32 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 6,172 | $10.01 | $61,810 | 124,723 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Exercise | 2024-04-03 4:21 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 442 | $0.6 | 82,485 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:21 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 442 | $0 | 82,485 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:19 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 50,000 | $0.4 | 96,000 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:19 pm | N/A 2026-02-11 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 50,000 | $0 | 96,000 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 8:36 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 13,100 | $0 | 60,046 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 8:34 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 13,100 | $0 | 50,769 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 8:31 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 13,100 | $0 | 50,629 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 8:30 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 35,500 | $0 | 175,850 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 8:29 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 7,475 | $0 | 30,149 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:21 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 5,504 | $0.6 | 82,927 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:21 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 5,504 | $0 | 82,927 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:17 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 31,739 | $2.19 | 31,739 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:17 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 31,739 | $0 | 31,739 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 4:20 pm | N/A 2025-12-01 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 60,773 | $0 | 60,773 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 4:20 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 233,000 | $0 | 60,773 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 4:18 pm | N/A 2025-12-01 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 60,773 | $0 | 60,773 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 4:18 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 233,000 | $0 | 60,773 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 4:17 pm | N/A 2025-12-01 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 8,463 | $0 | 8,463 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 4:17 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 65,600 | $0 | 8,463 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 4:15 pm | N/A 2025-12-01 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 25,908 | $0 | 25,908 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 4:15 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 200,800 | $0 | 25,908 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 4:09 pm | N/A 2025-12-01 | Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec | 46,284 | $0 | 46,284 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 4:09 pm | N/A 2031-02-15 | Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec | 186,100 | $0 | 46,284 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 4:48 pm | N/A 2033-09-18 | Stoke Therapeutics Inc. | STOK | SMITH IAN F Director | 96,340 | $0 | 96,340 (Direct) | View |
| 2023-03-27 Exercise | 2023-09-08 4:15 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 20,000 | $0.6 | 647,801 (Direct) | View |
| 2023-03-27 Exercise | 2023-09-08 4:15 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 20,000 | $0 | 647,801 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:26 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:26 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:25 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:24 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:24 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:23 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:22 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:37 pm | N/A 2033-03-14 | Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec | 74,700 | $0 | 74,700 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:36 pm | N/A 2033-03-14 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 131,000 | $0 | 131,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:35 pm | N/A 2033-03-14 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 131,000 | $0 | 131,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:33 pm | N/A 2033-03-14 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO | 131,000 | $0 | 131,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:33 pm | N/A 2033-03-14 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 355,000 | $0 | 355,000 (Direct) | View |
Ownership | 2023-03-17 3:40 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec | 0 | $0 | 222,448 (Direct) | View |